MARKET

VKTX

VKTX

Viking Therapeutics Inc
NASDAQ
27.33
-1.42
-4.94%
Opening 10:48 02/11 EST
OPEN
28.52
PREV CLOSE
28.75
HIGH
28.98
LOW
27.17
VOLUME
1.24M
TURNOVER
--
52 WEEK HIGH
43.15
52 WEEK LOW
18.92
MARKET CAP
3.09B
P/E (TTM)
-12.9025
1D
5D
1M
3M
1Y
5Y
1D
Here are the major earnings after the close Wednesday
Seeking Alpha · 4h ago
Viking Therapeutics's Earnings Outlook
Benzinga · 1d ago
Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week
Benzinga · 2d ago
Options Volatility and Implied Earnings Moves This Week, February 10 – February 13, 2026
TipRanks · 2d ago
Weekly Report: what happened at VKTX last week (0202-0206)?
Weekly Report · 2d ago
The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short
Seeking Alpha · 5d ago
Notable Thursday Option Activity: WFC, SITM, VKTX
NASDAQ · 5d ago
BUZZ-Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Reuters · 6d ago
More
About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.

Webull offers Viking Therapeutics Inc stock information, including NASDAQ: VKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTX stock methods without spending real money on the virtual paper trading platform.